Program Chair
Joel J. Heidelbaugh, MD, FAAFP, FACG
Clinical Professor
Department of Family Medicine
University of Michigan Medical School
Ann Arbor, MI
FACULTY
Chuck Vega, MD
Clinical Professor of Family Medicine
Assistant Dean for Culture and Community Education
University of California, Irvine School of Medicine
Irvine, CA
PROGRAM DESCRIPTION
We aim to create an initiative that healthcare providers can access to stay up-to-date on the current and novel emerging therapeutic options for the treatment of patients with Erosive Esophagitis (EE), while learning to apply patient-centric strategies and multidisciplinary coordination to the management of this disruptive and common disease complication.
TARGET AUDIENCE
This enduring activity is designed to meet the educational needs of gastroenterologists, primary care and internal medicine physicians, fellows, residents, nurse practitioners, physician assistants, and pharmacists.
LEARNING OBJECTIVES
- Discriminate between the mechanisms of action of current and novel emerging therapeutic options for the treatment of patients with EE
- Evaluate results from clinical trials assessing novel therapeutic options for EE
- Support multidisciplinary care for patients with EE to optimize safety and overall outcomes
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Joel J. Heidelbaugh, MD | Nothing to disclose. |
| Chuck Vega, MD | Received consulting fees from Boehringer Ingelheim and Exact Sciences. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Anne Knieriem, RN, MSN, has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
- Chris Drury MA, MS, MBA, Medical Director for Med Learning Group, has nothing to disclose.
- Marissa Mays-Verman, Senior Program Manager for Med Learning Group has nothing to disclose.
- Alexis Klinger, Associate Program Manager for Med Learning Group has nothing to disclose.
- Marcella Guarino, Program Coordinator for Med Learning Group has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group at [email protected]
RELEASED DATE: November 07, 2024
EXPIRATION DATE: November 07, 2025
Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
